Skip to main content
. 2022 Oct 26;14:3095–3103. doi: 10.2147/CMAR.S383787

Table 1.

Characteristics of Patients

Variables Group 1 (n = 40) Group 2 (n = 69) Group 3 (n = 122) p
Age (years)
(mean, range)
63
31–78
60
23–83
65
42–91
0.15
Male sex (number, %) 36, 90.0% 48, 69.6% 114, 93.4% < 0.01*
Treatment for primary site 0.11
Surgery (number, %) 26, 65.0% 60, 87.0% 110, 83.8%
Chemotherapy 8, 20.0% 4, 5.8% 12, 9.8%
Radiotherapy or ablation 1, 2.5% 1, 1.4% 2, 1.6%
Unknown 5, 12.5% 4, 5.8% 7, 5.8%
Disease-free interval (month) 33.6 ± 28.8 20.5 ± 14.7 27.1 ± 20.2 0.02*
Pathological maximum diameter (mm) 24.2 ± 28.9 30.8 ± 37.3 27.8 ± 24.3 0.09
Procedures (number, percent) 0.21
Sublobar 28, 70.0% 41, 59.4% 64, 52.5%
Lobectomy or more 12, 30.0% 28, 40.6% 58, 47.5%

Note: *p < 0.05 indicates significant values.